Infinity Pharmaceuticals (INFI)

Add to Watchlists
Create an Alert
10.15 -0.45  -4.25% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
INFI Price Chart
View All Events

INFI Events

Date Type Description
Feb 25 Misc Q4 2013 Infinity Conference Call and Webcast
Feb 04 Earnings Q4 2013 Infinity Earnings Results. Estimate: -0.83.
Nov 12 Misc Infinity Announces New Date and Time for Credit Suisse 2013 Healthcare Conference Presentation and Webcast
Nov 07 Misc Q3 2013 Infinity Pharmaceuticals, Inc. Earnings Conference Call
Nov 07 Earnings Q3 2013 Infinity Pharmaceuticals, Inc. Earnings Release. Estimate: -0.74.
Aug 08 Misc Infinity Announces the Date of Its Second Quarter 2013 Financial Results Conference Call and Webcast
Aug 08 Earnings Infinity Announces the Date of Its Second Quarter 2013 Financial Results. Estimate: -0.62.
Jun 11 Misc AGM Event for Infinity Pharmaceuticals Inc.
May 07 Misc Q1 2013 Infinity Pharmaceuticals, Inc. Earnings Conference Call
May 07 Earnings Infinity Announces the Date of Its First Quarter 2013 Financial Results. Estimate: -0.67.
View All Performance Charts

INFI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Infinity Pharmaceuticals is down 75.02% over the last year vs S&P 500 Total Return up 23.54%, Actelion up 72.03%, and Aratana Therapeutics up N/A.

Get Quote for

PDF Report for INFI

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download INFI Pro Report PDF
Advertisement

Portfolio Strategies Featuring INFI

Did Infinity Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

INFI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Infinity Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing & delivering medicines to people with difficult-to-treat diseases. Its primary product candidate is IPI-145, an oral inhibitor of phosphoinositide-3-kinase.

Recent Quotes

Symbol Price Chg Chg % Market Cap
INFI 10.15 -0.45 -4.25% 490.05M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.